Alba Bioscience Overview
- Founded
-
1998

- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Alba Bioscience General Information
Description
Manufacturer of monoclonal blood grouping reagents intended to supply vital products to hospitals, blood services and other diagnostic companies. The company's monoclonal blood grouping reagents are those reagents, instruments, and systems intended for use in diagnosis of disease or other conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent disease, enabling the hospitals to get a continous improvement of transfusion practiceand the ability to provide new diagnostic tests for changing health care needs, ultimately providing higher standards of patient care around the world.
Contact Information
- 21 Ellen's Glen Road
- Edinburgh EH17 7QT
- Scotland, United Kingdom
Alba Bioscience Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Alba Bioscience Patents
Alba Bioscience Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
GB-202016083-D0 | Method of detection | Inactive | 09-Oct-2020 | 0000000000 | |
GB-202016086-D0 | Detection assay | Inactive | 09-Oct-2020 | 0000000000 | |
GB-202016099-D0 | Detection method | Inactive | 09-Oct-2020 | 0000000000 | |
CA-2684112-A1 | Blood group antibody screening | Inactive | 10-Apr-2007 | 000000000 | |
EP-2132575-A2 | Blood group antibody screening | Inactive | 10-Apr-2007 | G01N33/80 |
Alba Bioscience Executive Team (1)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
John Allan | Chief Executive Officer |